[
    [
        {
            "time": "2023-10-01",
            "original_text": "智飞生物：公司控股股东、实控人解除质押690万股",
            "features": {
                "keywords": [
                    "智飞生物",
                    "控股股东",
                    "实控人",
                    "解除质押"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物：公司控股股东、实控人解除质押690万股",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "智飞生物(300122.SZ)：实控人蒋仁生解除质押690万股",
            "features": {
                "keywords": [
                    "智飞生物",
                    "蒋仁生",
                    "解除质押"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "智飞生物(300122.SZ)：实控人蒋仁生解除质押690万股",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "2020年M1-M5疫苗批签发报告：重点品种整体快速增长 国产13价肺炎疫苗等表现强劲",
            "features": {
                "keywords": [
                    "疫苗",
                    "批签发",
                    "国产13价肺炎疫苗",
                    "快速增长"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "2020年M1-M5疫苗批签发报告：重点品种整体快速增长 国产13价肺炎疫苗等表现强劲",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "【医药】五月份疫苗批签发：国产13价肺炎结合疫苗占比不断提升——行业专题报告——中性",
            "features": {
                "keywords": [
                    "疫苗",
                    "批签发",
                    "国产13价肺炎结合疫苗",
                    "占比提升"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【医药】五月份疫苗批签发：国产13价肺炎结合疫苗占比不断提升——行业专题报告——中性",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "【读财报】5月份重要股东增减持动态：医药生物公司减持频现 媒传行业分化 减持股份",
            "features": {
                "keywords": [
                    "医药生物",
                    "减持",
                    "频现",
                    "分化"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "【读财报】5月份重要股东增减持动态：医药生物公司减持频现 媒传行业分化 减持股份",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-10-01",
            "original_text": "5月重要股东增减持：医药生物减持频现 智飞生物、健帆生物居前 减持股份",
            "features": {
                "keywords": [
                    "医药生物",
                    "减持",
                    "智飞生物",
                    "健帆生物"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药",
                    "生物"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "5月重要股东增减持：医药生物减持频现 智飞生物、健帆生物居前 减持股份",
                "Correlation": 9,
                "Sentiment": 4,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]